These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 20305005

  • 21. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
    Amrein K, Amrein S, Drexler C, Dimai HP, Dobnig H, Pfeifer K, Tomaschitz A, Pieber TR, Fahrleitner-Pammer A.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):148-54. PubMed ID: 21994959
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sclerostin and DKK1 in primary hyperparathyroidism.
    Viapiana O, Fracassi E, Troplini S, Idolazzi L, Rossini M, Adami S, Gatti D.
    Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
    Cheng Q, Tang W, Sheu TJ, Du Y, Gan J, Li H, Hong W, Zhu X, Xue S, Zhang X.
    Clin Chim Acta; 2016 Apr 01; 455():87-92. PubMed ID: 26826396
    [Abstract] [Full Text] [Related]

  • 28. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE.
    J Bone Miner Res; 2011 Dec 01; 26(12):2804-11. PubMed ID: 21786318
    [Abstract] [Full Text] [Related]

  • 29. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
    Mirza FS, Padhi ID, Raisz LG, Lorenzo JA.
    J Clin Endocrinol Metab; 2010 Apr 01; 95(4):1991-7. PubMed ID: 20156921
    [Abstract] [Full Text] [Related]

  • 30. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
    Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH.
    J Bone Miner Res; 2011 Dec 01; 26(12):2812-22. PubMed ID: 21812027
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
    Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE.
    Diab Vasc Dis Res; 2014 Jan 01; 11(1):48-52. PubMed ID: 24227537
    [Abstract] [Full Text] [Related]

  • 33. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
    Gatti D, Viapiana O, Fracassi E, Idolazzi L, Dartizio C, Povino MR, Adami S, Rossini M.
    J Bone Miner Res; 2012 Nov 01; 27(11):2259-63. PubMed ID: 22692843
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparisons of serum sclerostin levels among patients with postmenopausal osteoporosis, primary hyperparathyroidism and osteomalacia.
    Kaji H, Imanishi Y, Sugimoto T, Seino S.
    Exp Clin Endocrinol Diabetes; 2011 Jul 01; 119(7):440-4. PubMed ID: 21667439
    [Abstract] [Full Text] [Related]

  • 37. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S, Tsuruya K, Tokumoto M, Yoshida H, Ooboshi H, Kitazono T.
    Nephrology (Carlton); 2015 Sep 01; 20(9):639-45. PubMed ID: 25974190
    [Abstract] [Full Text] [Related]

  • 38. Changes of serum sclerostin and Dickkopf-1 levels during the menstrual cycle. A pilot study.
    Liakou CG, Mastorakos G, Makris K, Fatouros IG, Avloniti A, Marketos H, Antoniou JD, Galanos A, Dontas I, Rizos D, Tournis S.
    Endocrine; 2016 Nov 01; 54(2):543-551. PubMed ID: 27601021
    [Abstract] [Full Text] [Related]

  • 39. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH, Hamdy NA, van der Meer RW, Jonker JT, Lamb HJ, Rijzewijk LJ, Diamant M, Romijn JA, Smit JW, Papapoulos SE.
    Eur J Endocrinol; 2012 Apr 01; 166(4):711-6. PubMed ID: 22267280
    [Abstract] [Full Text] [Related]

  • 40. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.
    Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, Reeve J.
    FASEB J; 2005 Nov 01; 19(13):1842-4. PubMed ID: 16123173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.